Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets, GLPG0634
GLPG0634-CL-329
Phase 3 small_molecule active
Quick answer
Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets, GLPG0634 for Polyarticular-course juvenile idiopathic arthritis is a Phase 3 program (small_molecule) at Alfasigma S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alfasigma S.p.A.
- Indication
- Polyarticular-course juvenile idiopathic arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active